IOTA Pharmaceuticals Ltd. We are a new-style pharmaceutical discovery services company. Built around the scientific expertise and industrial experience of its Founder Investors, and leveraged by networked resources, we possesse a wealth of discovery knowledge and experience which we place at your disposal. Two of our Founders, Dr Paul England and Dr David Bailey have managed large teams of drug discoverers within both major international pharmaceutical companies (Smith-Kline and Pfizer) and successful Californian biotech companies (Aurora and Incyte). Two other members of the founding team ( Dr Susan Boyd and Dr Iwan de Esch), currently participate in drug design and screening projects within in European centres of discovery excellence (in Cambridge and Amsterdam), while two more of our Founders, Sunil and Prashant Shah, have established globally-resourced businesses previously. Much of the R&D behind our company has been carried out at the Vrije Universiteit in Amsterdam, who are also Founding Investors. We are genuinely excited by and committed to drug discovery research, and will provide direct support, advice and encouragement to your discovery scientists. Between us, we will help you avoid many of the common pitfalls in drug discovery (e.g. deciding between alternative biochemical targets, synthetic routes, screening sequences or computational design approaches), to accelerate your projects.